Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
深度研究novocure股票：分析師觀點（4個評級）
The standing of NovoCure among...Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on NovoCure (NASDAQ:NVCR) in the last three months.
在過去三個月中，4位分析師針對NovoCure (納斯達克股票代碼:NVCR) 發佈了從看好到看淡不同的觀點評級。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.0, a high estimate of $40.00, and a low estimate of $18.00. Observing a 2.75% increase, the current average has risen from the previous average price target of $27.25.
分析師通過對12個月價格目標的評估提供了更深入的見解，顯示出平均目標爲$28.0，高估值爲$40.00，低估值爲$18.00。當前平均價格較上一次的目標價$27.25上漲了2.75%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The standing of NovoCure among...
通過對最近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間